# Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis

Study · id `cardio:ct-nct06225752` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06225752](<https://clinicaltrials.gov/study/NCT06225752>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06225752

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 5452 participants.

## Technical summary

Registry record NCT06225752. Randomized; quadruple masking; primary purpose treatment. Start 2024-06-15 (actual); primary completion 2028-04-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 5452 participants (planned count; ClinicalTrials.gov record NCT06225752, source copy `cardio:ctgov-nct06225752-2026-10-30`, retrieved 2026-10-31)
- Started: 2024-06-15 (actual) (ClinicalTrials.gov record NCT06225752, source copy `cardio:ctgov-nct06225752-2026-10-30`, retrieved 2026-10-31)
- Primary completion: 2028-04-30 (anticipated) (ClinicalTrials.gov record NCT06225752, source copy `cardio:ctgov-nct06225752-2026-10-30`, retrieved 2026-10-31)
- Completion: 2028-10-31 (anticipated) (ClinicalTrials.gov record NCT06225752, source copy `cardio:ctgov-nct06225752-2026-10-30`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT06225752, source copy `cardio:ctgov-nct06225752-2026-10-30`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06225752-2026-10-30`, retrieved 2026-10-31)

## The registry's words

- Brief title: Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis
- Condition: Ischemic Stroke
- Condition: TIA
- Intervention (Drug): Probucol
- Intervention (Drug): Placebo probucol
- Lead sponsor: First Affiliated Hospital of Wannan Medical College
- Lead sponsor class: OTHER
- Collaborator: Beijing Tiantan Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: First Affiliated Hospital of Wannan Medical College (`cardio:org-first-affiliated-hospital-of-wannan-medical-college`)
- Registry lists this organization as a collaborator: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)

## Provenance

Content hash: 458851f2b4ad4c3ae3070d75316d3f9c7c6811fc8dc18348a9badc2619a8ca77
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
